PLX Protalix BioTherapeutics, Inc.
$2.53▲ +2.02%
Healthcare
Other
After hours
$2.53▲ +0.00%
Oct 27, 4:01 PM ET
Volume 448.3K
Avg Volume (10D) 826.0K
Key Metrics & Fundamentals
Market Cap
$203.85M
P/E Ratio
11.0
Div Yield
0.00%
52W Range
1.65 - 3.19
% vs 50 MA
-3.80%
% vs 200 MA
5.16%
RSI-14
42.4
MACD Histogram
-0.0300
Beta (1Y vs SPY)
1.07
Free Cash Flow
-$10.99M
Gross Rev
$19.90M
Gross Profit
$12.13M
EBITDA
$5.76M
COGS
$7.76M
Operating Exp
$7.46M
Operating Income
$4.67M
EBIT
$4.67M
Pretax Income
$4.86M
Net Income
$3.78M
EPS (Diluted)
0.05
Price & Volume History
Loading chart…
Recent News
Protalix BioTherapeutics to Present at the Stifel 2026 Healthcare Conference
PR Newswire · Oct 26, 2026 6:50 AM ET
Guerrilla RF Heads These 3 Top Penny Stocks To Watch
Simply Wall St. · Oct 24, 2026 10:09 PM ET
3 Oil And Gas Stocks to Watch as Supply Shock Risks Rise
Simply Wall St. · Oct 10, 2026 9:12 PM ET
Netflix downgraded, SanDisk initiated: Wall Street's top analyst calls
The Fly · Sep 22, 2026 9:44 AM ET
Protalix BioTherapeutics to Participate in Upcoming September 2026 Investor Conferences
PR Newswire · Sep 8, 2026 6:45 AM ET
Protalix BioTherapeutics, Inc. Q2 2026 Earnings Call Summary
Moby · Aug 13, 2026 10:01 PM ET
PLX: Elfabrio Estimates Up
Zacks Small Cap Research · Aug 13, 2026 1:03 PM ET
Protalix BioTherapeutics Inc (PLX) (Q2 2026) Earnings Call Highlights: Net Income Surges to $3. ...
GuruFocus.com · Aug 12, 2026 7:04 PM ET
Protalix: Q2 Earnings Snapshot
Associated Press · Aug 12, 2026 6:58 AM ET
Protalix BioTherapeutics Reports Second Quarter 2026 Financial and Business Results
PR Newswire · Aug 12, 2026 6:50 AM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See PLX's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.